Literature DB >> 7048924

Effect of acyclovir on various murine in vivo and in vitro immunologic assay systems.

R P Quinn, G Wolberg, J Medzihradsky, G B Elion.   

Abstract

In two in vitro tests, lymphocyte-mediated cytotoxicity and neutrophil chemotaxis, acyclovir showed no inhibitory effects at concentrations as high as 600 microM. The compound inhibited rosette formation with nonimmune mouse lymphocytes in vitro by approximately 50 percent at 15.8 microM. The significance of this inhibition is unclear. In four in vivo tests in mice which measured humoral and cell-mediated immunity (complement-dependent cellular cytotoxicity, complement-independent cellular cytotoxicity, delayed hypersensitivity and graft versus host reaction) acyclovir showed no inhibitory effects at single doses up to 200 mg/kg given on day 2 after antigenic stimulation. Four daily doses of acyclovir at 50 mg/kg per day had no effect on the numbers of hemolytic IgM antibody-forming cells in the spleen when assayed on day 4. At the higher dosage of 100 mg/kg per day for four days, there was a slight reduction in the numbers of these cells. There was no significant decrease in hemagglutinin or hemolysin antibody titers after four daily doses of acyclovir up to 200 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048924     DOI: 10.1016/0002-9343(82)90065-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Effect of six virustatic nucleoside analogues on the development of fetal rat thymus in organ culture.

Authors:  M Foerster; U Kastner; R Neubert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

2.  Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.

Authors:  C S Foster; N P Barney
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 3.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.